Welcome to our dedicated page for Bwx Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BWX Technologies, Inc. filings document the regulatory record of a NYSE-listed nuclear manufacturing and engineering company serving government and commercial markets. Its disclosures cover operating and financial results, segment performance, backlog-related business activity, risk factors, and material events connected to nuclear propulsion, nuclear fuel, and commercial nuclear operations.
BWXT’s SEC filings also address governance and capital structure. Recent records include proxy materials and annual meeting voting results, board and executive officer matters, registered common stock information, material agreements, and convertible senior notes due 2030 with related subsidiary guarantees.
BWX Technologies director Jan Bertsch reported an acquisition of 35.47 Dividend Equivalent Rights (DERs) tied to existing restricted stock units. These DERs were granted at an exercise price of $0.00 and increase her directly held DER balance to 2,242.48 units.
According to the disclosure, the DERs accrue on nine restricted stock unit grants for which she has elected to defer receipt of the underlying shares. Each RSU and each DER represents a contingent right to receive one share of BWX common stock, and the DERs will be delivered proportionately with the related deferred RSUs.
Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Gerhard F. Burbach received a routine compensation-related grant of 19.620 Dividend Equivalent Rights tied to existing restricted stock units. Following this award, he holds 777.920 such rights, each representing a contingent right to receive one share of BWXT common stock, delivered in line with his RSU deferral election.
JASKA JAMES M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director James M. Jaska received a grant of dividend equivalent rights tied to existing deferred restricted stock units. On the transaction date, he was awarded 23.95 dividend equivalent rights at a price of $0.00 per right, increasing his total to 1,110.39 such rights. Each dividend equivalent right and related restricted stock unit represents a contingent right to receive one share of BWX common stock, delivered in proportion to the underlying RSUs according to his deferral election. This filing reflects routine equity-based compensation rather than an open-market stock purchase or sale.
JABLONSKY DANIEL L reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Daniel L. Jablonsky reported an automatic compensation-related award of 1.29 Dividend Equivalent Rights (DERs) tied to previously granted restricted stock units. Following this grant, he holds 1.45 DERs. Each RSU and DER represents a contingent right to receive one share of BWXT common stock, to be delivered in line with his prior deferral election.
Krieg Kenneth J reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Kenneth J. Krieg received a grant of 30.59 Dividend Equivalent Rights on June 5, 2026. These rights accrued on nine restricted stock unit (RSU) grants for which he previously elected to defer receipt of the underlying shares.
Each RSU and each Dividend Equivalent Right represents a contingent right to receive one share of BWX Technologies common stock. Following this grant, Krieg holds a total of 1,450.81 Dividend Equivalent Rights, which will be delivered proportionately over time in line with the deferred RSUs.
Melvin Leland D reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Melvin Leland D received a grant of 13.06 Dividend Equivalent Rights tied to previously awarded restricted stock units. Each right represents a contingent claim on one share of BWXT common stock and will be delivered on the same deferred schedule as the related RSUs, bringing his total such rights to 228.4.
PIASECKI NICOLE WEYERHAEUSER reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Nicole Weyerhaeuser Piasecki received a grant of 6.6 dividend equivalent rights linked to previously awarded restricted stock units. After this award, she holds 53.41 dividend equivalent rights, each representing a contingent right to receive one share of BWXT common stock, delivered proportionately with the related RSUs.
Richardson John M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director John M. Richardson received a grant of 13.910 Dividend Equivalent Rights on 2026-06-05, bringing his total to 337.870 DERs. These rights accrue on deferred restricted stock units, with each RSU and DER representing a contingent right to receive one share of BWXT common stock, delivered proportionately under his deferral election.
BWX Technologies, Inc. President and CEO Rex D. Geveden sold 10,000 shares of common stock in open-market transactions. The sales occurred on 2026-05-12 at weighted average prices around $203–$207 per share, executed in four separate trades.
The filing states these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-08-11, indicating they were scheduled in advance. Following the transactions, Geveden directly owns 202,491 shares of BWX Technologies common stock.
BWX Technologies, Inc. SVP & Chief Financial Officer Michael Thomas Fitzgerald reported an option-related share sale and exercises. On May 11, 2026, he sold 2,417 shares of common stock in an open-market transaction at $209.25 per share. The filing also shows he exercised employee stock options for a total of 2,417 shares of common stock at exercise prices of $106.64 and $100.83 per share. Following these transactions, he directly holds 6,884 common shares, and continues to hold employee stock options that expire in 2034 and 2035 and vest in three equal annual installments beginning in 2025 and 2026.